Gujarat Themis Biosyn Limited (NSE: 506879) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Sachin Dinesh Patel -- Director Rajneesh Anand -- Consultant Tushar
Categories
Health Care
Rainbow Children’s Medicare Q4FY23 Earnings
An Indian hospital network with many specialties in paediatrics, obstetrics, and gynaecology is run by Rainbow Children's Medicare Limited. The business provides
Cipla Limited Q4 FY23 Earnings Conference Call Insights
Key highlights from Cipla Limited (CIPLA) Q4 FY23 Earnings Concall Management Update: [00:05:08] CIPLA said its U.S. business crossed $200 million in
Cipla Limited (CIPLA) Q4 FY23 Earnings Concall Transcript
Cipla Limited (NSE:CIPLA) Q4 FY23 Earnings Concall dated May. 12, 2023. Corporate Participants: Ajinkya Pandharkar -- Investor Relations Umang Vohra -- Managing Director and Global Chief
Solara Active Pharma Sciences Limited (SOLARA) Q4 FY23 Earnings Concall Transcript
Solara Active Pharma Sciences Limited (NSE:SOLARA) Q4 FY23 Earnings Concall dated May. 12, 2023. Corporate Participants: Abhishek Singhal -- Investor Relations Jitesh Devendra -- Managing Director
Dr Lal PathLabs Ltd Q4 FY23 Earnings Conference Call Insights
Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY23 Earnings Concall Q&A Highlights: [00:17:48] Rahul Agarwal from InCred Capital asked if
Solara Active Pharma Q4FY23 results out, revenue grows by 6%
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.
Neuland Laboratories Limited (NEULANDLAB) Q4 FY23 Earnings Concall Transcript
Neuland Laboratories Limited (NSE:NEULANDLAB) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Ravi Udeshi -- Investor Relations Abhijit Majumdar. -- Chief Financial Officer Saharsh
Orchid Pharma Ltd (ORCHPHARMA) Q4 FY23 Earnings Concall Transcript
Orchid Pharma Ltd (NSE:ORCHPHARMA) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Manish Dhanuka -- Managing Director Mridul Dhanuka -- Director Analysts: Himanshu Upadhyay -- O3
Sanofi India Ltd (SANOFI) Q4 FY23 Earnings Concall Transcript
Sanofi India Ltd (NSE:SANOFI) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Radhika Kartik Shah -- Company Secretary and Compliance Officer Rodolfo
Medico Remedies Q4FY23 Earnings Story
Medico Remedies is engaged in the business of Manufacture of allopathic pharmaceutical preparations. Financial Results: Medico Remedies Limited reported Total Income for
Neuland Laboratories Q4FY23 Earnings Story
Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial Results: Neuland
Orchid Pharma Limited Q4FY23 Earnings Story
Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It
Dr. Reddy’s Laboratories Q4 FY23 Earnings Conference Call Insights
Key highlights from Dr. Reddy's Laboratories (DRREDDY) Q4 FY23 Earnings Concall Q&A Highlights: [00:21:55] Mikhaila at Barclays asked more details about the
Lupin Ltd (LUPIN) Q4 FY23 Earnings Concall Transcript
Lupin Ltd (NSE:LUPIN) Q4 FY23 Earnings Concall dated May. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director, Global Chief
Aarti Industries Ltd Q4 FY23 Earnings Conference Call Insights
Key highlights from Aarti Industries Ltd (AARTIIND) Q4 FY23 Earnings Concall Management Update: [00:08:20] AARTIIND said its EBITDA growth guidance for FY24
Novartis India Limited Q4FY23 Earnings Story
The main line of business for Novartis India Ltd. is the wholesale distribution of medicines and medical supplies.It brings different medications into
Procter & Gamble Hygiene & Health Care Q4FY23; 3% Fall in Profits
Procter & Gamble Hygiene & Health Care’s total income in Q4FY23 fell 8% to ₹ 898 crores. Consolidated Profit After Tax came
Lupin Limited Q4FY23 Earnings Story
Lupin manufactures pharmaceuticals as a line of business. Globally, APIs, biotechnology products, and generic formulations are all developed and marketed by Lupin
Sanofi Ltd Q4FY23 results out, revenue soars by 4%
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Company has three brands (Lantus, Allegra, Combiflam) in top
Beta Drugs Limited (BETA) Q4 FY23 Earnings Concall Transcript
Beta Drugs Limited (NSE:BETA) Q4 FY23 Earnings Concall dated May. 09, 2023. Corporate Participants: Rahul Batra -- Chairman and Managing Director Nipun Arora -- Chief Financial